AWM
BNTX icon

Aberdeen Wealth Management’s BioNTech BNTX Stock Holding History

Aberdeen Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.9K Buy
+880
New +$82.8K 0.04% 189
2022
Q1 		– Sell
-880
Closed -$227K – 170
2021
Q4 		$227K Hold
880
– – 0.15% 135
2021
Q3 		$240K Buy
+880
New +$280K 0.23% 110

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Aberdeen Wealth Management's BNTX Position: Q2 2026 in Review

Aberdeen Wealth Management opened a new position in BioNTech (BNTX) in Q2 2026: 880 shares worth $81.9K. The stake represents 0.04% of the portfolio and ranks #189 among its holdings. This is a return to the name: Aberdeen Wealth Management previously reported a position in BNTX as recently as Q4 2021.

Aberdeen Wealth Management first reported a position in BNTX in Q3 2021 and has held it in 3 quarters since. The position peaked at $240K in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Aberdeen Wealth Management held 880 shares of BioNTech worth $81.9K as of Q2 2026.
  • BioNTech was a new Aberdeen Wealth Management position in Q2 2026.
  • BioNTech made up 0.04% of Aberdeen Wealth Management's portfolio in Q2 2026, its #189 holding.
  • Aberdeen Wealth Management first reported a position in BioNTech in Q3 2021 and has held it in 3 quarters since.
  • Aberdeen Wealth Management's BioNTech position peaked at $240K in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.